As of 2024-12-13, the Intrinsic Value of Pfizer Inc (PFE) is
3.54 USD. This Pfizer valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 25.37 USD, the upside of Pfizer Inc is
-86.00%.
The range of the Intrinsic Value is (3.40) - 100.06 USD
Pfizer Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(3.40) - 100.06 |
3.54 |
-86.0% |
| DCF (Growth 10y) |
1.52 - 160.42 |
12.22 |
-51.8% |
| DCF (EBITDA 5y) |
(4.49) - (2.09) |
(1,234.50) |
-123450.0% |
| DCF (EBITDA 10y) |
(2.59) - 0.71 |
(1,234.50) |
-123450.0% |
| Fair Value |
13.76 - 13.76 |
13.76 |
-45.78% |
| P/E |
9.10 - 25.00 |
17.28 |
-31.9% |
| EV/EBITDA |
(1.25) - 23.46 |
9.26 |
-63.5% |
| EPV |
65.86 - 91.58 |
78.72 |
210.3% |
| DDM - Stable |
11.98 - 90.45 |
51.21 |
101.9% |
| DDM - Multi |
15.64 - 79.60 |
24.98 |
-1.5% |
Pfizer Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
143,771.53 |
| Beta |
-0.04 |
| Outstanding shares (mil) |
5,666.99 |
| Enterprise Value (mil) |
210,380.53 |
| Market risk premium |
4.60% |
| Cost of Equity |
6.37% |
| Cost of Debt |
4.63% |
| WACC |
5.67% |